Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi's Cancer Drug May Set New Standard
TheStreet.com
Thursday, March 4, 2010 - 7:13am
tags:
Sanofi, cabazitaxel, Medivation, JNJ, Provenge, Dendreon, prostate cancer
Why It's Time to Sell Cephalon
Seeking Alpha
Wednesday, March 3, 2010 - 9:38pm
tags:
Cephalon
Questcor: Biotech Winner
TheStreet.com
Wednesday, March 3, 2010 - 6:04pm
tags:
Questcor Pharmaceuticals
FDA Sees Increasing Number Of Insulin Pump Problems
WSJ Online
Wednesday, March 3, 2010 - 5:36pm
tags:
FDA, insulin pumps, Roche, Medtronic
Drug developers show little reaction to Obama push on health care reform
Yahoo/AP
Wednesday, March 3, 2010 - 5:01pm
tags:
healthcare reform, Abbott Laboratories, Amgen, AstraZeneca
Will Andreotti Merge Bristol-Myers Squibb?
Pharmalot
Wednesday, March 3, 2010 - 4:59pm
tags:
Bristol-Myers Squibb, M&A, Eli Lilly
Bullish on Pozen
Yahoo/Zacks.com
Wednesday, March 3, 2010 - 4:57pm
tags:
Pozen, GSK, AstraZeneca
Pharma reports 26,000 layoffs in 2010
Fierce Pharma
Wednesday, March 3, 2010 - 12:04pm
tags:
layoffs
Covidien launches generic version of Actiq
Yahoo/AP
Wednesday, March 3, 2010 - 12:00pm
tags:
Covidien, generics, Actiq
Pfizer’s Jeff Kindler Gets A Hefty Raise
Pharmalot
Wednesday, March 3, 2010 - 11:59am
tags:
Pfizer, Jeff Kindler, executive pay, Pharma CEOs
The Incompetent Monopolist: Genzyme's Drug Screwups Invite Attacks by Shire, Pfizer
BNET Pharma
Wednesday, March 3, 2010 - 11:57am
tags:
Genzyme, Shire, Pfizer, Gaucher disease
Drug stocks climb; Medivation sinks on drug study
Marketwatch
Wednesday, March 3, 2010 - 11:56am
tags:
Medivation, dimebon, drug stocks, Pfizer
Pfizer Said to Set Sights on German Drug Maker
NY Times, NY
Wednesday, March 3, 2010 - 11:55am
tags:
Pfizer, generics, Ratiopharm, Teva Pharmaceuticals, Actavis, M&A
Lessons From Mead Johnson's IPO Stock Spin-Off
Seeking Alpha
Wednesday, March 3, 2010 - 11:54am
tags:
Mead Johnson, Bristol-Myers Squibb, IPOs
Lower Q4 Loss for Human Genome
Yahoo/Zacks.com
Wednesday, March 3, 2010 - 11:52am
tags:
Human Genome Sciences, earnings
Bristol-Myers, Allergan in $413M pain drug deal
Yahoo/AP
Wednesday, March 3, 2010 - 11:51am
tags:
Bristol-Myers Squibb, Allergan, partnerships
NicOx Sells Eye Treatment Rights to Bausch & Lomb
Bloomberg
Wednesday, March 3, 2010 - 11:44am
tags:
NicOx, Bausch & Lomb, glaucoma
Pfizer, Medivation’s Drug Fails in Alzheimer’s Study
Bloomberg
Wednesday, March 3, 2010 - 11:43am
tags:
Pfizer, Medivation, dimebon, Alzheimer's disease
Transition Therapeutics and Lilly in diabetes deal
Yahoo/AP
Wednesday, March 3, 2010 - 11:42am
tags:
Transition Therapeutics, partnerships, Eli Lilly, diabetes
Pfizer's Newly Approved Vaccine Should Be Huge Growth Driver
Seeking Alpha
Wednesday, March 3, 2010 - 11:40am
tags:
Pfizer, vaccines, Prevnar 13

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.